D.E. Shaw & Co’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

D.E. Shaw & Co’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-15,000	Closed	-$2.59M	–	4048
2015 Q1	$2.59M	Sell	15,000 -10,000	-40%	-$1.47M	﹤0.01%	1833
2014 Q4	$2.87M	Hold	25,000	–	–	﹤0.01%	1970
2014 Q3	$3.91M	Buy	25,000 +15,000	+150%	+$2.17M	0.01%	1736
2014 Q2	$1.23M	Hold	10,000	–	–	﹤0.01%	2744
2014 Q1	$1.04M	Sell	10,000 -10,000	-50%	-$1.02M	﹤0.01%	2998
2013 Q4	$1.8M	Hold	20,000	–	–	﹤0.01%	2629
2013 Q3	$1.34M	Buy	+20,000	New	+$1.38M	﹤0.01%	2778

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's SLXP Position: Q2 2015 in Review

D.E. Shaw & Co sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 258,455 shares — an estimated $44.7M sold.

D.E. Shaw & Co first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $44.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

D.E. Shaw & Co reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
D.E. Shaw & Co sold 258,455 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $44.7M.
D.E. Shaw & Co first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
D.E. Shaw & Co's SALIX PHARMACEUTICALS LTD DEL position peaked at $44.7M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.